Value Add VC tracks 1 company Pershing Square has invested in and 1 venture round it took part in (1 as lead).
Pershing Square key facts (as of )
| Fact | Value | Source |
|---|---|---|
| Type | Venture capital firm | Value Add VC classification |
| Venture rounds tracked | 1 (led 1, joined 0) 1 in the last 12 months | Recent deals table on this page (each round cites its source) |
| Portfolio companies tracked | 1 | Portfolio list on this page |
Recent deals we track
1Track record: led 1 and participated in 0 of 1 tracked venture round · 1 in the last 12 months · led 1 Series D
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Precision Neuroscience | Series D | Led | $250M | ~$1B | Pershing SquareLeadunverifiedAckman Oxman InstituteLeadunverifiedDuquesne Family OfficeunverifiedB CapitalARK InvestInvusMubadala CapitalMirae Asset CapitalKorea Investment PartnersHitachi VenturesJSL Health Capital | GlobeNewswire |
Is something wrong on this page?
We track Pershing Square but have little verified detail yet.
Recent changes
- Sep 24, 2026Sep 24, 2026Invested in Precision Neuroscience (Series D, $250M) GlobeNewswire
Portfolio
1 totalCo-Investors
8Value Add Research
Latest Pulse
- Sep 28, 2026Health AI Raised $655M+ In Just Three DealsOpenEvidence, Precision Neuroscience and Rightway alone pulled in more than $655 million in late-September rounds, underscoring how much AI capital is now flowing into healthcare specifically.→
- Sep 25, 2026OpenEvidence Raises $250M Led By Andreessen HorowitzOpenEvidence, the Miami-based clinical search platform for physicians, raised a new $250 million round led by hospital systems and Andreessen Horowitz.→
- Sep 25, 2026Precision Neuroscience Raises $250M For Brain ImplantsPrecision Neuroscience raised $250 million to advance its brain-computer interface technology, backed by Bill Ackman's Pershing Square and the Ackman Oxman Institute.→
- Sep 24, 2026AI Agent Security Just Had A $1.15B WeekIsland, Cyera and BigHat Biosciences alone raised more than $1.1 billion this week to build the layer that governs what AI agents can access and do -- evidence the market has already priced in the exact failure mode this issue's lead story just demonstrated.→
- Sep 24, 2026Precision Neuroscience Hits $1B Valuation On $250M RaisePrecision Neuroscience closed an oversubscribed $250 million Series D co-led by Bill Ackman's Pershing Square and his new Ackman Oxman Institute, valuing the brain-computer interface company at just over $1 billion.→
- Sep 24, 2026Ackman Co-Leads Precision Neuroscience's $250M RoundPrecision Neuroscience closed an oversubscribed $250 million Series D co-led by Bill Ackman's Pershing Square, valuing the brain-computer interface company at just over $1 billion as it scales past 100 patient procedures.→
Pershing Square FAQ
What stage does Pershing Square invest at?
In the rounds Value Add VC tracks, Pershing Square's deals were most often Series D (1); it led 1 Series D.
What companies has Pershing Square backed?
Companies Value Add VC tracks as Pershing Square investments include Precision Neuroscience.
Who does Pershing Square co-invest with most?
In the rounds Value Add tracks, Pershing Square most often invests alongside ARK Invest (1 shared deal), B Capital (1 shared deal), Duquesne Family Office (1 shared deal), Hanwha Asset Management (1 shared deal), Hitachi Ventures (1 shared deal).
Sources & methodologyshow
- GlobeNewswireprimary source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.